Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biomaterials and Biopolymers / / edited by Avi Domb, Boaz Mizrahi, Shady Farah
| Biomaterials and Biopolymers / / edited by Avi Domb, Boaz Mizrahi, Shady Farah |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (280 pages) |
| Disciplina | 610.28 |
| Collana | AAPS Introductions in the Pharmaceutical Sciences |
| Soggetto topico |
Pharmaceutical chemistry
Biomaterials Pharmacology Drug delivery systems Vaccines - Biotechnology Pharmaceutics Drug Delivery Biomaterials-Vaccines |
| ISBN |
9783031361357
3031361350 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction to Biomaterials -- Biodegradable Polymers -- Natural and semi-natural polymers -- Fundamentals and Biomedical Applications of Smart Hydrogels -- Engineering biomaterials for nucleic acid-based therapies -- Mechanics of Biomaterials for Regenerative Medicine -- Biomaterials for controlled drug delivery applications -- BIOMATERIALS APPLICATION: IMPLANTS -- Living Biomaterials -- Therapeutic Polymer Conjugates and their Characterization -- Biocompatibility of Polymers -- Sterilization techniques of biomaterials (implants and medical devices). |
| Record Nr. | UNINA-9910746300103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biopharmaceutical Manufacturing : Progress, Trends and Challenges / / edited by Ralf Pörtner
| Biopharmaceutical Manufacturing : Progress, Trends and Challenges / / edited by Ralf Pörtner |
| Autore | Pörtner Ralf |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (497 pages) |
| Disciplina | 571.6 |
| Collana | Cell Engineering |
| Soggetto topico |
Cytology
Biomedical engineering Biotechnology Biochemical engineering Pharmaceutical chemistry Vaccines - Biotechnology Biomaterials Cell Biology Biomedical Engineering and Bioengineering Bioprocess Engineering Pharmaceutics Biomaterials-Vaccines |
| ISBN |
9783031456695
3031456696 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Manufacturing of Recombinant Therapeutic Proteins -- Chapter 1. Single-Use Systems in Biopharmaceutical Manufacture: State of the Art and Recent Trends (Jossen et al.) -- Chapter 2. Recent Developments in Bioprocess Monitoring Systems (Rahmatnejad et al.) -- Chapter 3. Advances in Characterization of Industrial Bioreactors for Cell Culture Process (Fitschen et al.) -- Chapter 4. Continuous Bioprocessing for Upstream Process - Perfusion Process (Chotteau et al.) -- Chapter 5. Continuous Bioprocessing for Downstream (Gerstweiler) -- Chapter 6. Towards Digital Twin for Biopharmaceutical Processes: Concept and Progress (Ding et al.) -- Chapter 7. Integrated Process and Supply Chain Design and Optimization (Triantafyllou et al.) -- Chapter 8. Production of Complex Proteins in Plants – From Farming to Manufacturing (Nausch et al.) -- Chapter 9. Manufacturing of Recombinant Proteins Using Quality by Design (QbD) Methodology: Current Trend and Challenges (Shin and Landauer) -- Chapter 10. Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraints (Schmidt et al.) -- Chapter 11. Biopharma 4.0: Digital Technologies Driving Smart Manufacturing (Nargund et al.) -- Part II: Manufacturing Aspects of Cell and Gene Therapy -- Chapter 12. Essential Aspects of Mesenchymal Stem Cell Manufacturing (Fleischhammer et al.) -- Chapter 13. Towards a Continuous Production of Human Mesenchymal Stromal Cells in a Chemically Defined Medium: Opportunities and Challenges for a Robust and Scalable Expansion Process (Tasto and Salzig) -- Chapter 14. Biomanufacturing Aspects of Gene Therapy (Warnock) -- Chapter 15. Manufacturing and Quality of Advanced Therapeutics: Cellular Therapies, CAR-T and Gene Therapies (van den Bos et al.). |
| Record Nr. | UNINA-9910800113003321 |
Pörtner Ralf
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotechnology in India - Reworking A Strategy / / edited by George John, Amulya K. Panda
| Biotechnology in India - Reworking A Strategy / / edited by George John, Amulya K. Panda |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (364 pages) |
| Disciplina | 660.6072054 |
| Soggetto topico |
Biotechnology
Vaccines - Biotechnology Biomaterials Agricultural biotechnology Biomaterials-Vaccines Agricultural Biotechnology |
| ISBN | 981-9708-96-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_Transforming Indian Agriculture through Genome Editing Technologies: Challenges and Opportunities -- Chapter 2_ GM Crops for Sustainable Agriculture and Food Security in Indian Scenario -- Chapter 3_Reaping the benefits of gene modulations in animals in the era of genomics -- Chapter 4_ Marine Biotechnology in India-status and the unfolding opportunities -- Chapter 5_Novel vaccines for viral respiratory diseases -- Chapter 6_Artificial Intelligence in Healthcare - India Case Study -- Chapter 7_International Cancer Genome Consortium (ICGC) - India Project on Genomics of Oral Cancer: Lessons learned -- Chapter 8_Fermentation Technology: Driving Biotechnology to Work -- Chapter 9_Lignocellulosic biomass based biorefinery using fungus and fungal enzymes: Indian perspective and global trend -- Chapter 10_Innovations in the Pharma and Biopharma industries: Role of Academy-Industry Interactions -- Chapter 11_Catalysing and accelerating a new phase in Indian Bio Pharma -- Chapter 12_Regulation of Genetically Modified Organisms and Products therefrom in India -- Chapter 13_Bio-economy and the role of Human Resources development in Biotechnology. K Kannan -- Chapter 14_Nano-technology applications in Biology- the game changing opportunities for India. . |
| Record Nr. | UNINA-9910896534703321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Conquest of Viruses : A History of Viral Vaccines / / by Van G. Wilson
| The Conquest of Viruses : A History of Viral Vaccines / / by Van G. Wilson |
| Autore | Wilson Van G |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (XIV, 400 p. 14 illus., 12 illus. in color.) |
| Disciplina |
579.2
616.96 |
| Soggetto topico |
Virology
Vaccines - Biotechnology Biomaterials Medicine - History Biomaterials-Vaccines History of Medicine |
| ISBN |
9783031875625
3031875621 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Vaccines in the 21st Century -- Chapter 2: Smallpox and Immunity: Success Precedes Science -- Chapter 3: Rabies: From Attenuation to Inactivation -- Chapter 4: Yellow Fever: America Goes to War -- Chapter 5: Influenza: An Elusive and Evasive Foe -- Chapter 6: Poliovirus – An Insidious Plague -- Chapter 7: Measles/Mumps/Rubella (MMR): The Childhood Trifecta -- Chapter 8: Hepatitis B Virus – Blood, Sex, and Drugs -- Chapter 9: Hepatitis A Virus – Feces, Food, and Fomites -- Chapter 10: Herpes Varicella Zoster – The Other Pox (Chickenpox) -- Chapter 11: Rotavirus – The Democratic Virus -- Chapter 12: Human Papillomaviruses - An Ancient Enemy -- Chapter 13: SARS-Coronavirus-2 - The Unexpected Plague -- Chapter 14: Respiratory Syncytial Virus – A Shape-Shifting Adversary -- Chapter 15: The Fight Continues - Virus Without Vaccines. |
| Record Nr. | UNINA-9910992774703321 |
|
Wilson Van G
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The COVID-19 Aftermath : Volume I: Ongoing Challenges / / edited by Nima Rezaei
| The COVID-19 Aftermath : Volume I: Ongoing Challenges / / edited by Nima Rezaei |
| Autore | Rezaei Nima |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (453 pages) |
| Disciplina | 614.592414 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Medicine - Research
Biology - Research Vaccines - Biotechnology Biomaterials Therapeutics Diagnosis Public health Bioethics Biomedical Research Biomaterials-Vaccines Public Health |
| ISBN | 3-031-61939-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Global Challenges after a Global Challenge: Lessons Learned from the COVID-19 Pandemic -- Coronavirus Anatomy and its Analytical Approaches for Targeting COVID-19 -- Ethanol Inhalation as a Method to Denature the Spike Protein of SARS-CoV-2 -- Frailty in Critically Ill Patients with COVID-19: The Lessons Learned -- Respiratory Support in COVID-19-Related Respiratory Failure: Lessons Learnt -- Pathophysiology of COVID‐19‐related Extrapyramidal Disorders -- Acute Encephalopathies in SARS-CoV2 Infection: A Clinical and Neuroimaging Perspective -- Addressing Long COVID Sequelae and Neurocovid: Neuropsychological Scenarios and Neuroimaging Findings -- COVID-19 Vaccination and Therapeutics -- Controversies in COVID-19: Diagnostic Evaluation and Management in Neuro-COVID -- Computational Drug Design Strategies for Fighting the COVID-19 Pandemic -- The Potential of Natural Products in the Management of COVID-19 -- Role of Imaging in Diagnosis and Management of COVID-19: Evidence-based Approaches -- Does the COVID-19 Vaccination Reduce the Risk to Transmit SARS-CoV-2 to Others? -- Sudden Hearing Loss Waves: The Effect of COVID-19 Infection and Vaccination on the Inner Ear -- The Views of the Citizens Regarding COVID-19 Vaccination -- The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region -- Interest Groups and COVID-19 in Africa -- Lessons Learned about Trauma Related to Racial Discrimination During COVID-19 in the United States -- Media and Interpersonal Channels Uses and Preferences among International Students in the US during the COVID-19 Pandemic -- Estimating the Real Impact of the COVID-19 Pandemic in Kazakhstan: Factors Associated with Detection of the "True Infections" -- The Impact of COVID-19 on Children and Adolescents with Chronic Illness -- Management of COVID-19 in Ophthalmology -- Obesity, Physical Activity, and COVID-19 -- Global Breakdowns and Transformations in the World of Sports After COVID-19. |
| Record Nr. | UNINA-9910887883903321 |
|
Rezaei Nima
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19: Search for a vaccine / / by Patric U. B. Vogel
| COVID-19: Search for a vaccine / / by Patric U. B. Vogel |
| Autore | Vogel Patric U. B. |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Spektrum, , 2023 |
| Descrizione fisica | 1 online resource (60 pages) |
| Disciplina | 362.1962414 |
| Collana | essentials |
| Soggetto topico |
Vaccines - Biotechnology
Biomaterials Pharmacy Pharmaceutical chemistry Biomaterials-Vaccines Medicinal Chemistry |
| ISBN |
9783658389314
9783658389307 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Coronaviruses: history and viral properties -- Vaccine technologies, approaches against COVID-19, clinical phases -- Attenuated live vaccines -- Vector vaccines and virus-like particles -- Inactivated vaccines -- Recombinant proteins (protein subunits) -- Nucleic acid-based vaccines -- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity -- Summary. |
| Record Nr. | UNINA-9910633930303321 |
|
Vogel Patric U. B.
|
||
| Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Spektrum, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Freeze-drying Technology in Pharmaceutical and Biomedical Product Development : Impact, Progress and Challenges of Lyophilization / / edited by Dalapathi Gugulothu, Sumit Sharma, Meenakshi Kanwar Chauhan
| Freeze-drying Technology in Pharmaceutical and Biomedical Product Development : Impact, Progress and Challenges of Lyophilization / / edited by Dalapathi Gugulothu, Sumit Sharma, Meenakshi Kanwar Chauhan |
| Autore | Gugulothu Dalapathi |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (503 pages) |
| Disciplina | 615.6 |
| Altri autori (Persone) |
SharmaSumit
Kanwar ChauhanMeenakshi |
| Collana | Biomedical and Life Sciences Series |
| Soggetto topico |
Drug delivery systems
Vaccines - Biotechnology Biomaterials Biotechnology Nanobiotechnology Materials - Analysis Colloids Drug Delivery Biomaterials-Vaccines Materials Characterization Technique |
| ISBN |
9789819502219
9789819502202 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction to Freeze Drying, its Operation, and the Different Types of Freeze Dryers -- Chapter 2. Development of the Freeze-Drying Cycle, Cryoprotectant Selection, and Characterization.-Chapter 3. New physical methods for characterization of freeze-dried goods -- Chapter 4. Impact of Freeze-Drying on Pharmaceutical Product’s Morphology, Physical Characteristics, and In Vitro Release Kinetics -- Chapter 5. Stability of Colloidal Dispersions Using Freeze-Drying Technology -- Chapter 6. Progress and Challenges in Enhancing the Stability of Targeted Drug Delivery Vehicles.-Chapter 7. Use of Freeze Drying for Pharmaceutical Microencapsulation -- Chapter 8. Freeze drying of Pharmaceutical products for injectable and oral use -- Chapter 9. Palatalisation of pharmaceuticals using freeze-drying technology -- Chapter 10. Solid-state delivery and stabilization of therapeutic proteins using freeze-drying technology -- Chapter 11. Using Freeze-Drying to Stabilize Formulations of Monoclonal Antibodies -- Chapter 12. Freeze Drying of Vaccines to Increase Immunity -- Chapter 13. Enhanced Preservation of Stem Cell-Derived Extracellular Vesicles Through Freeze-Drying -- Chapter 14. Development of a hydrogel-nanofibrous scaffold via freeze-drying -- Chapter 15. Freeze-drying: Increasing probiotic stability. |
| Record Nr. | UNINA-9911021968003321 |
|
Gugulothu Dalapathi
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Genomics, proteomics, and vaccines [[electronic resource] /] / editor, Guido Grandi
| Genomics, proteomics, and vaccines [[electronic resource] /] / editor, Guido Grandi |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley, c2004 |
| Descrizione fisica | 1 online resource (345 p.) |
| Disciplina | 572.8/6 |
| Altri autori (Persone) | GrandiGuido |
| Soggetto topico |
Genomics
Vaccines - Biotechnology Proteomics |
| ISBN |
1-280-26948-0
9786610269488 0-470-09392-7 0-470-01253-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Genomics, Proteomics and Vaccines -- Contents -- Preface -- List of contributors -- PART 1: INTRODUCTION -- 1 Vaccination: Past, Present and Future -- 1.1 Introduction -- 1.2 Vaccination: the past -- 1.3 Vaccination: the present -- 1.4 Vaccination: the future -- 1.5 Conclusion: the intangible value of vaccination -- 2 Bioinformatics, DNA Microarrays and Proteomics in Vaccine Discovery: Competing or Complementary Technologies? -- 2.1 Introduction -- 2.2 From genome sequence to vaccine discovery -- 2.3 A case study: the anti-meningococcus B vaccine -- 2.4 Comparison of the three approaches -- 2.5 Conclusions: a 'nomics' approach to vaccine discovery -- PART 2: TECHNOLOGIES -- 3 Genome Sequencing and Analysis -- 3.1 Introduction -- 3.2 Genome sequencing -- 3.3 Genome analysis -- 3.4 Conclusion -- 4 Understanding DNA Microarrays: Sources and Magnitudes of Variances in DNA Microarray Data Sets -- 4.1 Introduction -- 4.2 DNA array formats -- 4.3 Data analysis methods -- 4.4 Sources and magnitudes of noise in DNA microarray experiments -- 4.5 Conclusions -- Acknowledgements -- 5 The Proteome, Anno Domini Two Zero Zero Three -- 5.1 Introduction -- 5.2 Some definitions -- 5.3 What methods exist to tackle the proteome complexity?5.4 Quantitative proteomics -- 5.5 Pre-fractionation in proteome analysis -- 5.6 Multi-dimensional chromatography -- 5.7 Protein chip arrays -- 5.8 Imaging mass spectrometry -- Acknowledgements -- 6 Mass Spectrometry in Proteomics -- 6.1 Introduction -- 6.2 MS technology -- 6.3 Principle of protein identification based on MS data -- 6.4 Proteomics workflows -- 7 High Throughput Cloning, Expression and Purification Technologies -- 7.1 Introduction -- 7.2 Gene cloning -- 7.3 Protein expression -- 7.4 High-throughput protein purification -- 7.5 Validation of the pipeline and outlook7.6 Conclusion -- PART 3: APPLICATIONS -- 8 Meningococcus B: from Genome to Vaccine -- 8.1 Meningococcus, a major cause of bacterial meningitis -- 8.2 Group B meningococcus as an example of reverse vaccinology -- 8.3 Conclusions -- 9 Vaccines Against Pathogenic Streptococci -- 9.1 Introduction -- 9.2 Comparative genomics of streptococci -- 9.3 A vaccine against group B streptococcus -- 9.4 A vaccine against group A streptococcus -- 9.5 Conclusions -- 10 Identification of the 'Antigenome' - a Novel Tool for Design and Development of Subunit Vaccines Against Bacterial Pathogens -- 10.1 Introduction -- 10.2 Small DNA insert libraries - a tool to cover a pathogen's 'antigenome' -- 10.3 Proper display platforms -- 10.4 Selected human sera to provide imprints of pathogen encounters -- 10.5 Cognate antibodies reveal the 'antigenome' of a pathogen -- 10.6 How to retrieve from the 'antigenome' the candidate antigens for vaccine development -- 10.7 Summary and discussion -- 11 Searching the Chlamydia Genomes for New Vaccine Candidates -- 11.1 Old problems and new perspectives for chlamydial vaccines. |
| Record Nr. | UNINA-9910145752603321 |
| Chichester ; ; Hoboken, NJ, : Wiley, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Genomics, proteomics, and vaccines / / editor, Guido Grandi
| Genomics, proteomics, and vaccines / / editor, Guido Grandi |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley, c2004 |
| Descrizione fisica | 1 online resource (345 p.) |
| Disciplina | 572.8/6 |
| Altri autori (Persone) | GrandiGuido |
| Soggetto topico |
Genomics
Vaccines - Biotechnology Proteomics |
| ISBN |
9786610269488
9781280269486 1280269480 9780470093924 0470093927 9780470012536 0470012536 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Genomics, Proteomics and Vaccines -- Contents -- Preface -- List of contributors -- PART 1: INTRODUCTION -- 1 Vaccination: Past, Present and Future -- 1.1 Introduction -- 1.2 Vaccination: the past -- 1.3 Vaccination: the present -- 1.4 Vaccination: the future -- 1.5 Conclusion: the intangible value of vaccination -- 2 Bioinformatics, DNA Microarrays and Proteomics in Vaccine Discovery: Competing or Complementary Technologies? -- 2.1 Introduction -- 2.2 From genome sequence to vaccine discovery -- 2.3 A case study: the anti-meningococcus B vaccine -- 2.4 Comparison of the three approaches -- 2.5 Conclusions: a 'nomics' approach to vaccine discovery -- PART 2: TECHNOLOGIES -- 3 Genome Sequencing and Analysis -- 3.1 Introduction -- 3.2 Genome sequencing -- 3.3 Genome analysis -- 3.4 Conclusion -- 4 Understanding DNA Microarrays: Sources and Magnitudes of Variances in DNA Microarray Data Sets -- 4.1 Introduction -- 4.2 DNA array formats -- 4.3 Data analysis methods -- 4.4 Sources and magnitudes of noise in DNA microarray experiments -- 4.5 Conclusions -- Acknowledgements -- 5 The Proteome, Anno Domini Two Zero Zero Three -- 5.1 Introduction -- 5.2 Some definitions -- 5.3 What methods exist to tackle the proteome complexity?5.4 Quantitative proteomics -- 5.5 Pre-fractionation in proteome analysis -- 5.6 Multi-dimensional chromatography -- 5.7 Protein chip arrays -- 5.8 Imaging mass spectrometry -- Acknowledgements -- 6 Mass Spectrometry in Proteomics -- 6.1 Introduction -- 6.2 MS technology -- 6.3 Principle of protein identification based on MS data -- 6.4 Proteomics workflows -- 7 High Throughput Cloning, Expression and Purification Technologies -- 7.1 Introduction -- 7.2 Gene cloning -- 7.3 Protein expression -- 7.4 High-throughput protein purification -- 7.5 Validation of the pipeline and outlook7.6 Conclusion -- PART 3: APPLICATIONS -- 8 Meningococcus B: from Genome to Vaccine -- 8.1 Meningococcus, a major cause of bacterial meningitis -- 8.2 Group B meningococcus as an example of reverse vaccinology -- 8.3 Conclusions -- 9 Vaccines Against Pathogenic Streptococci -- 9.1 Introduction -- 9.2 Comparative genomics of streptococci -- 9.3 A vaccine against group B streptococcus -- 9.4 A vaccine against group A streptococcus -- 9.5 Conclusions -- 10 Identification of the 'Antigenome' - a Novel Tool for Design and Development of Subunit Vaccines Against Bacterial Pathogens -- 10.1 Introduction -- 10.2 Small DNA insert libraries - a tool to cover a pathogen's 'antigenome' -- 10.3 Proper display platforms -- 10.4 Selected human sera to provide imprints of pathogen encounters -- 10.5 Cognate antibodies reveal the 'antigenome' of a pathogen -- 10.6 How to retrieve from the 'antigenome' the candidate antigens for vaccine development -- 10.7 Summary and discussion -- 11 Searching the Chlamydia Genomes for New Vaccine Candidates -- 11.1 Old problems and new perspectives for chlamydial vaccines. |
| Record Nr. | UNINA-9910828470503321 |
| Chichester ; ; Hoboken, NJ, : Wiley, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
History of Rabies in the Americas: From the Pre-Columbian to the Present, Volume I : Insights to Specific Cross-Cutting Aspects of the Disease in the Americas / / edited by Charles E. Rupprecht
| History of Rabies in the Americas: From the Pre-Columbian to the Present, Volume I : Insights to Specific Cross-Cutting Aspects of the Disease in the Americas / / edited by Charles E. Rupprecht |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (328 pages) |
| Disciplina | 616.953 |
| Collana | Fascinating Life Sciences |
| Soggetto topico |
Immunology
Virology Medicine - History Veterinary medicine Vaccines - Biotechnology Biomaterials History of Medicine Veterinary Science Biomaterials-Vaccines |
| ISBN |
9783031250521
9783031250514 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The world in flux – the Columbian Exchange D. Domenici -- Glimpses into the past: new world contributions towards understanding the basic etiology, pathobiology & treatment of rabies, Drishya Kurup et al -- The Diversity, Evolution and Emergence of Rabies Virus in the Americas, Edward C. Holmes & Erin H. Harvey -- The ecological range and principles of wildlife rabies virus perpetuation in the Americas, Amy T. Gilbert -- Historical Laboratory Contributions Supporting Rabies Diagnosis and Disease Prevention and Control in the Americas, Susan A. Nadin-Davis, et al -- Progression from nerve tissue vaccines to recombinant biologics, H. Ertl -- Wildlife Rabies Management in the New World: Prevention, Control and Elimination in Mesocarnivores, R. Chipman et al -- Management of vampire bats and rabies: past, present, and future, Tonie Rocke & Daniel Streicker -- Conflicting Perspectives on a Rabies Outbreak in a Venezuelan Rainforest, 2007-2008, C. Briggs -- Rabies, Medicine, andCulture: Dogs, Disease, and Urban Life in the United States, 1840-1920, Jessica Wang -- Historical disparities in health: rabies surveillance, risk factors and prevention, Amira Roess et al -- The Health Economics of Rabies in the Americas: An Historical Summary and a Synthesis of the Literature, S.A. Shwiff -- Towards the elimination of canine rabies in the americas: governance of a regional program, M. Vigilato et al -- Musing Over Non-technical Criticalities of Rabies Prevention and Control in the Americas, Victor J. Del Rio Vilas & Gilberto Montibeller. |
| Record Nr. | UNINA-9910717416703321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
